However, blood pressure reduction with ACE inhibitors and AT1R antagonists still represents the first-line treatment for CKD patients, and could not fully prevent the progression of renal disease and CKD patients are still requiring more efficacious treatment options. Here, ACE is linked to kidney disorder.